A Fundamental Change in Leukemia Treatment After Discovery of Cell Mechanism

A new cell mechanism that could lead to a fundamental change in the diagnosis and treatment of leukaemia has been identified by researchers.

A Fundamental Change in Leukemia Treatment After Discovery of Cell Mechanism

A team in the University of Kent's pharmacy school conducted a study that discovered that leukaemia cells release a protein, known as galctin-9, that prevents a patient's own immune system from killing cancerous blood cells.

‘Existing treatment strategies consist of aggressive chemotherapy and stem cell transplantation, which often do not result in effective remission of the disease.’

Acute Myeloid Leukaemia (AML) -- a type of blood cancer that affects over 250,000 people every year worldwide -- progresses rapidly because its cells are capable of avoiding the patient's immune surveillance. It does this by inactivating the body's immune cells, cytotoxic T lymphocytes and natural killer (NK) cells.

This is because of a lack of understanding of the molecular mechanisms that allow malignant cells to escape attack by the body's immune cells.

Now the researchers at the Medway School of Pharmacy, led by Dr Vadim Sumbayev, Dr Bernhard Gibbs and Professor Yuri Ushkaryov, have found that leukaemia cells -- but not healthy blood cells -- express a receptor called latrophilin 1 (LPHN1). Stimulation of this receptor causes these cancer cells to release galectin-9, which then prevents the patient's immune system from fighting the cancer cells.

The discovery of this cell mechanism paves the way for new 'biomarkers' for AML diagnosis, as well as potential targets for AML immune therapy, say the researchers.

'Targeting this pathway will crucially enhance patients own immune defences, helping them to eliminate leukaemia cells', said Dr Sumbayev. He added that the discovery has the potential to also be beneficial in the treatment of other cancers.

Your comments are automatically posted once they are submitted. All comments are however constantly reviewed for spam and irrelevant material (such as product or personal advertisements, email addresses, telephone numbers and website address). Such insertions do not conform to our policy and 'Terms of Use' and are either deleted or edited and republished.Please keep your comments brief and relevant.This section may also have questions seeking help. If you have the information you are welcome to respond, but please ensure that the information so provided is genuine and not misleading.

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment.Full Disclaimer